Latest Breaking News On - Matt scalo - Page 6 : comparemela.com

Myriad Genetics Names George Daneker Jr , MD, as President and Chief Clinical Officer of Oncology

Myriad Genetics Names George Daneker Jr , MD, as President and Chief Clinical Officer of Oncology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGeorge daneker jrPaulj diazGlenn farrellMark verrattiMatt scaloLoyla collegeOncology clinical programUniversity of marylandGenetics incExchange commissionChief clinical officerSystem vice presidentMedical directorSystem corporate chief medical officerFormerly cancer treatment centers

Myriad Genetics Names George Daneker Jr , MD, as President and Chief Clinical Officer of Oncology

Myriad Genetics Names George Daneker Jr , MD, as President and Chief Clinical Officer of Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaulj diazGeorge daneker jrMatt scaloGlenn farrellMark verrattiLoyola collegeUniversity of marylandExchange commissionGenetics incOncology clinical programChief clinical officerSystem vice presidentMedical directorSystem corporate chief medical officerFormerly cancer treatment centers

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics - Myriad Genetics (NASDAQ:MYGN)

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select

United statesGlenn farrellPaulj diazMatt scaloIntermountain health systemExchange commissionGenetics incIntermountain precision genomicTumor testPrecise liquid testPrecise tumor testPrecise tumorPrecise liquidIntermountain healthcareSolid tumorPrivate securities litigation reform act

Myriad Genetics to Acquire Precise Tumor, Precise Liquid

SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today.

United statesPaulj diazGlenn farrellMatt scaloGenetics incExchange commissionIntermountain health systemIntermountain precision genomicTumor testPrecise liquid testPrecise tumor testPrecise tumorPrecise liquidIntermountain healthcareSolid tumorPrivate securities litigation reform act

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesShelly cummngsGlenn farrellMatt scaloOncology medical affairsAmerican society of clinical oncologyGenetics incSociety of surgical oncologyExchange commissionGenetics applauds new germline testing guidelineBreast cancerAmerican societyClinical oncologySurgical oncologyVice presidentHereditary cancer test